Annual Drug Patent Expirations for ROZLYTREK
Rozlytrek is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug.
This drug has one hundred and one patent family members in twenty-nine countries.
The generic ingredient in ROZLYTREK is entrectinib. One supplier is listed for this compound. Additional details are available on the entrectinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com